Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Downgrades Duck Creek Technologies to Hold

Needham analyst Mayank Tandon downgrades Duck Creek Technologies (NASDAQ:DCT) from Buy to Hold.

byBenzinga Newsdesk

January 9, 2023

1 minute read

Needham analyst Mayank Tandon downgrades Duck Creek Technologies (NASDAQ:DCT) from Buy to Hold.

Stealth BioTherapeutics Q2 EPS $(0.03) Misses $(0.02) Estimate

By Bill Haddad

Today, 8:47 AM

Stealth BioTherapeutics (NASDAQ:MITO) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.02) by 50 percent. This is a 50 percent decrease over losses of $(0.02) per share

MITO

News

5 Value Stocks In The Communication Services Sector

By Benzinga Insights

Today, 8:47 AM

Understanding Value Stocks

CANG

Citigroup Maintains Buy on Edison, Raises Price Target to $79

By Benzinga Newsdesk

Today, 8:47 AM

Citigroup analyst Ryan Levine maintains Edison (NYSE:EIX) with a Buy and raises the price target from $67 to $79.

EIX

Barclays Maintains Overweight on Couchbase, Lowers Price Target to $26

By Benzinga Newsdesk

Today, 8:47 AM

Barclays analyst Raimo Lenschow maintains Couchbase (NASDAQ:BASE) with a Overweight and lowers the price target from $30 to $26.

BASE

Needham Downgrades Duck Creek Technologies to Hold

Related Posts

Stealth BioTherapeutics Q2 EPS $(0.03) Misses $(0.02) Estimate

5 Value Stocks In The Communication Services Sector

Citigroup Maintains Buy on Edison, Raises Price Target to $79

Barclays Maintains Overweight on Couchbase, Lowers Price Target to $26